National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant vaccinia prostate-specific antigen vaccine
A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific antigen vaccine stimulates the host immune system to mount a cytotoxic T-cell response against tumor cells expressing PSA. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:Prostate Specific Antigen Expressing Vaccinia Virus Vaccine
rV-PSA
RV-PSA (RECOMB VACCINIA/PSA-CV-1)
rV-PSA vaccine
vaccinia prostate-specific antigen vaccine
vaccinia-prostate-specific antigen vaccine
vaccinia-PSA vaccine
US brand name:PROSTVAC
Abbreviation:VPSA



Previous:recombinant tissue plasminogen activator, recombinant TNF-related apoptosis-inducing ligand, recombinant transforming growth factor-beta-2, recombinant tumor necrosis factor family protein, recombinant tyrosinase-related protein-2
Next:recombinant vaccinia-B7.1 vaccine, recombinant vaccinia-CEA(6D)-TRICOM vaccine, recombinant vaccinia-MUC-1 vaccine, recombinant vaccinia-multiepitope melanoma peptides-B7.1-B7.2 vaccine, recombinant vaccinia-NY-ESO-1 vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov